Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 918 trades; $10.3T in total
Open-market sales: 1,145 trades; $2B in total
Insiders filing: 485 insiders; Last 7 days
Companies with several buyers: 34; Last 7 days

Cellectar Biosciences CLRB

		Trade type
James V. CarusoCEO	Cellectar BiosciencesCLRB	Open-market buy	05/07	05/11	8,680 sh	$2.88	$24,998.4	+74.6%
Jarrod LongcorCOO	Cellectar BiosciencesCLRB	Open-market buy	05/07	05/11	8,680 sh	$2.88	$24,998.4	+73.7%
John NeisDirector	Cellectar BiosciencesCLRB	Open-market sale	25/12/12	25/12/16	198 sh	$3.70	$732.6	−95.2%
James V. CarusoCEO	Cellectar BiosciencesCLRB	Open-market buy	25/07/02	25/07/03	10,000 sh	$4.99	$49,900	+610.5%
Jarrod LongcorCOO	Cellectar BiosciencesCLRB	Open-market buy	25/07/02	25/07/03	10,000 sh	$4.99	$49,900	+361.3%
Chad J. KoleanCFO	Cellectar BiosciencesCLRB	Open-market buy	25/07/02	25/07/03	5,000 sh	$4.99	$24,950	+352.6%
Jarrod LongcorCOO	Cellectar BiosciencesCLRB	Open-market buy	25/01/10	25/03/12	30,000 sh	$0.28	$8,400	+56.5%